Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5184970
Max Phase: Preclinical
Molecular Formula: C59H84N8O13
Molecular Weight: 1113.36
Associated Items:
ID: ALA5184970
Max Phase: Preclinical
Molecular Formula: C59H84N8O13
Molecular Weight: 1113.36
Associated Items:
Canonical SMILES: COC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccc(OC(C)(C)C)cc1)N(C)C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)N(C)C(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C
Standard InChI: InChI=1S/C59H84N8O13/c1-36(2)31-44(52(71)61-38(5)54(73)66(10)47(55(74)67-30-18-23-46(67)57(76)78-11)33-40-24-26-42(27-25-40)80-59(6,7)8)62-50(70)34-48(68)43(32-39-19-14-12-15-20-39)63-53(72)45(28-29-49(60)69)65(9)56(75)51(37(3)4)64-58(77)79-35-41-21-16-13-17-22-41/h12-17,19-22,24-27,36-38,43-48,51,68H,18,23,28-35H2,1-11H3,(H2,60,69)(H,61,71)(H,62,70)(H,63,72)(H,64,77)/t38-,43-,44-,45-,46-,47+,48-,51-/m0/s1
Standard InChI Key: CZXLJTCMHQXVJW-UTMJBIBJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1113.36 | Molecular Weight (Monoisotopic): 1112.6158 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Li Z, Li H, Jiang F, Wang Z, Zhang W.. (2022) Cathepsin D inhibitors based on tasiamide B derivatives with cell membrane permeability., 57 [PMID:35121401] [10.1016/j.bmc.2022.116646] |
Source(1):